BMI1 Antikörper (Internal Region)
Kurzübersicht für BMI1 Antikörper (Internal Region) (ABIN789019)
Target
Alle BMI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-100, Internal Region
-
Kreuzreaktivität
- Rind (Kuh), Hund, Huhn, Katze, Human, Maus, Primate, Kaninchen, Ratte (Rattus)
-
Aufreinigung
- affinity purified
-
Immunogen
- A synthetic peptide made to an internal region (within AA 1-100) of the human Bmi1 protein. [Swiss-Prot# P35226].
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- -20 °C
-
-
- BMI1 (BMI1 Polycomb Ring Finger Oncogene (BMI1))
-
Andere Bezeichnung
- Bmi1
-
Hintergrund
- Bmi1 induces telomerase activity and immortalizes human mammary epithelial cells. Bmi1 extends the replicative life span of human fibroblasts by suppressing the p16-dependent senescence pathway. It has also been termed an oncogene with aberrant expression in various carcinomas. It has been shown to be a negative regulator of p19Arf, Ink4a (p14Arf) and tp53 known tumor repressors. Ablation of Bmi1 is required for short term survival of cancer cells. In addition, Bmi1 expression promotes HSC self-renewal. These findings highlight the importance of epigenetic regulation in HSC self-renewal and identify PcG genes as potential targets for therapeutic HSC manipulation.
-
UniProt
- P35226
-
Pathways
- Zellzyklus, Autophagie
Target
-